دورية أكاديمية
Alcohol consumption and breast cancer risk by estrogen receptor status: in a pooled analysis of 20 studies.
| العنوان: | Alcohol consumption and breast cancer risk by estrogen receptor status: in a pooled analysis of 20 studies. |
|---|---|
| المؤلفون: | Jung S; Department of Nutrition, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA, sjung@epi.umaryland.edu., Wang M; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA, Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Anderson K; Division of Epidemiology and Community Health, School of Public Health, and Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Baglietto L; Cancer Epidemiology Centre, Cancer Council Victoria, Carlton, VIC, Australia, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Melbourne, VIC, Australia., Bergkvist L; Department of Surgery and Centre for Clinical Research, Central Hospital, Västerås, Sweden., Bernstein L; Division of Cancer Etiology, Department of Population Science, Beckman Research Institute and City of Hope National Medical Center, Duarte, CA, USA., van den Brandt PA; Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Brinton L; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, Bethesda, MD, USA., Buring JE; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA, Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Eliassen AH; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA, Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Falk R; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, Bethesda, MD, USA., Gapstur SM; Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA., Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, Carlton, VIC, Australia, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Melbourne, VIC, Australia., Goodman G; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Hoffman-Bolton J; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Horn-Ross PL; Cancer Prevention Institute of California, Fremont, CA, USA., Inoue M; Epidemiology and Prevention Group, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan, AXA Department of Health and Human Security, Graduate School of Medicine, University of Tokyo, Tokyo, Japan., Kolonel LN; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA., Krogh V; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lof M; Department of Clinical and Experimental Medicine, University of Linköping, Linköping, Sweden., Maas P; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, Bethesda, MD, USA., Miller AB; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Neuhouser ML; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Park Y; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St Louis, St Louis, MO, USA., Robien K; Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, George Washington University, Washington, DC, USA., Rohan TE; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA., Scarmo S; Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, NY, USA., Schouten LJ; Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands., Sieri S; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Stevens VL; Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA., Tsugane S; Epidemiology and Prevention Group, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan., Visvanathan K; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Wilkens LR; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA., Wolk A; Division of Nutritional Epidemiology, National Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden., Weiderpass E; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway, Department of Research, Cancer Registry of Norway, Oslo, Norway and Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland., Willett WC; Department of Nutrition, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA, Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Zeleniuch-Jacquotte A; Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, New York, NY, USA., Zhang SM; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Zhang X; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Ziegler RG; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, Bethesda, MD, USA., Smith-Warner SA; Department of Nutrition, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. |
| المصدر: | International journal of epidemiology [Int J Epidemiol] 2016 Jun; Vol. 45 (3), pp. 916-28. Date of Electronic Publication: 2015 Aug 28. |
| نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 7802871 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3685 (Electronic) Linking ISSN: 03005771 NLM ISO Abbreviation: Int J Epidemiol Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [London] Oxford University Press. |
| مواضيع طبية MeSH: | Alcohol Drinking/*epidemiology , Breast Neoplasms/*epidemiology , Receptors, Estrogen/*genetics, Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/genetics ; Dietary Supplements ; Ethanol/metabolism ; Female ; Folic Acid/metabolism ; Humans ; Middle Aged ; Multivariate Analysis ; Proportional Hazards Models ; Prospective Studies ; Risk Factors ; Surveys and Questionnaires ; Young Adult |
| مستخلص: | Background: Breast cancer aetiology may differ by estrogen receptor (ER) status. Associations of alcohol and folate intakes with risk of breast cancer defined by ER status were examined in pooled analyses of the primary data from 20 cohorts. Methods: During a maximum of 6-18 years of follow-up of 1 089 273 women, 21 624 ER+ and 5113 ER- breast cancers were identified. Study-specific multivariable relative risks (RRs) were calculated using Cox proportional hazards regression models and then combined using a random-effects model. Results: Alcohol consumption was positively associated with risk of ER+ and ER- breast cancer. The pooled multivariable RRs (95% confidence intervals) comparing ≥ 30 g/d with 0 g/day of alcohol consumption were 1.35 (1.23-1.48) for ER+ and 1.28 (1.10-1.49) for ER- breast cancer (Ptrend ≤ 0.001; Pcommon-effects by ER status: 0.57). Associations were similar for alcohol intake from beer, wine and liquor. The associations with alcohol intake did not vary significantly by total (from foods and supplements) folate intake (Pinteraction ≥ 0.26). Dietary (from foods only) and total folate intakes were not associated with risk of overall, ER+ and ER- breast cancer; pooled multivariable RRs ranged from 0.98 to 1.02 comparing extreme quintiles. Following-up US studies through only the period before mandatory folic acid fortification did not change the results. The alcohol and folate associations did not vary by tumour subtypes defined by progesterone receptor status. Conclusions: Alcohol consumption was positively associated with risk of both ER+ and ER- breast cancer, even among women with high folate intake. Folate intake was not associated with breast cancer risk. (© The Author 2015; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.) |
| References: | Am J Clin Nutr. 2009 Feb;89(2):624-33. (PMID: 19116331) Int J Cancer. 2001 Feb 15;91(4):563-7. (PMID: 11251982) Int J Cancer. 2010 Aug 1;127(3):685-95. (PMID: 19960437) Br J Cancer. 2004 Jan 12;90(1):153-9. (PMID: 14710223) Cancer Causes Control. 2002 Jun;13(5):407-15. (PMID: 12146845) N Engl J Med. 1999 May 13;340(19):1449-54. (PMID: 10320382) Cancer Lett. 2001 Apr 26;165(2):131-7. (PMID: 11275361) Am J Epidemiol. 2007 Mar 15;165(6):667-76. (PMID: 17204515) JAMA. 1999 May 5;281(17):1632-7. (PMID: 10235158) Epidemiology. 2001 Jul;12(4):420-8. (PMID: 11416780) Int J Cancer. 2014 Mar 15;134(6):1504-10. (PMID: 24037751) Am J Epidemiol. 1996 Jul 15;144(2):165-74. (PMID: 8678048) Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):2004-8. (PMID: 16103452) FEBS J. 2009 Apr;276(8):2175-91. (PMID: 19292860) Am J Epidemiol. 2009 Aug 1;170(3):308-17. (PMID: 19541857) Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1104-7. (PMID: 12376515) Biometrics. 1996 Jun;52(2):536-44. (PMID: 8672702) Eur J Cancer Prev. 2015 May;24(3):209-14. (PMID: 24743350) Am J Clin Nutr. 2002 Oct;76(4):883-8. (PMID: 12324304) Asian Pac J Cancer Prev. 2012;13(10):5105-11. (PMID: 23244119) Int J Cancer. 2007 Aug 15;121(4):911-4. (PMID: 17455245) Am J Epidemiol. 1999 Aug 15;150(4):327-33. (PMID: 10453808) Control Clin Trials. 1986 Sep;7(3):177-88. (PMID: 3802833) Am J Clin Nutr. 2010 Jun;91(6):1708-15. (PMID: 20410093) Cancer Epidemiol Biomarkers Prev. 2003 Aug;12(8):713-20. (PMID: 12917201) IARC Sci Publ. 2002;156:69-70. (PMID: 12484128) Cancer Causes Control. 2000 Mar;11(3):239-47. (PMID: 10782658) J Natl Cancer Inst. 2000 Dec 20;92(24):2018-23. (PMID: 11121464) Am J Epidemiol. 1986 Jul;124(1):17-27. (PMID: 3521261) Cancer Res. 1994 Apr 1;54(7 Suppl):2038s-2043s. (PMID: 8137335) J Natl Cancer Inst. 2014 Dec 12;107(1):367. (PMID: 25505228) Alcohol Alcohol. 2012 May-Jun;47(3):204-12. (PMID: 22459019) Alcohol Res. 2013;35(1):25-35. (PMID: 24313162) Am J Epidemiol. 2006 Jun 1;163(11):1053-64. (PMID: 16624970) Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):27-32. (PMID: 15668472) J Natl Cancer Inst. 2003 Mar 5;95(5):373-80. (PMID: 12618502) Eur J Clin Nutr. 2006 Feb;60(2):280-6. (PMID: 16234832) Am J Clin Nutr. 2006 Apr;83(4):895-904. (PMID: 16600944) Breast Cancer Res Treat. 2010 Jul;122(1):199-210. (PMID: 19949857) Am J Epidemiol. 2009 May 15;169(10):1251-9. (PMID: 19318616) Int J Cancer. 2008 Apr 15;122(8):1832-41. (PMID: 18067133) Br J Cancer. 1997;75(1):149-55. (PMID: 9000614) Am J Epidemiol. 2014 Oct 1;180(7):705-17. (PMID: 25150269) Am J Epidemiol. 1996 Jan 15;143(2):177-86. (PMID: 8546119) Eur J Cancer. 2009 Mar;45(5):843-50. (PMID: 19095438) Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2787-90. (PMID: 18086790) Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):161-4. (PMID: 12582027) J Natl Cancer Inst. 2005 Nov 2;97(21):1601-8. (PMID: 16264180) Am J Clin Nutr. 2009 Jan;89(1):347-53. (PMID: 19056579) BMJ. 2009 Jul 09;339:b2587. (PMID: 19589821) Breast Cancer Res Treat. 2011 Feb;126(1):185-92. (PMID: 20711652) J Womens Health Gend Based Med. 2000 Jan-Feb;9(1):19-27. (PMID: 10718501) Am J Clin Nutr. 2005 Dec;82(6):1308-19. (PMID: 16332665) Breast Cancer Res Treat. 2013 Jan;137(2):337-47. (PMID: 23239150) Control Clin Trials. 2000 Dec;21(6 Suppl):273S-309S. (PMID: 11189684) PLoS One. 2012;7(3):e32389. (PMID: 22427832) BMJ. 2005 Oct 8;331(7520):807. (PMID: 16087654) Br J Cancer. 2011 Aug 23;105(5):709-22. (PMID: 21772329) JAMA. 2011 Nov 2;306(17):1884-90. (PMID: 22045766) J Natl Cancer Inst. 1999 Mar 17;91(6):547-56. (PMID: 10088626) JAMA. 1998 Feb 18;279(7):535-40. (PMID: 9480365) Cancer Epidemiol Biomarkers Prev. 2008 Dec;17 (12 ):3444-9. (PMID: 19064560) Am J Epidemiol. 2003 Aug 1;158(3):280-7. (PMID: 12882951) Cancer. 2002 Jan 15;94(2):500-11. (PMID: 11900235) Breast Cancer Res Treat. 2009 Aug;116(3):551-62. (PMID: 18785003) J Natl Cancer Inst. 2010 Sep 22;102(18):1422-31. (PMID: 20733117) |
| معلومات مُعتمدة: | U01 CA063673 United States CA NCI NIH HHS; P30 CA015704 United States CA NCI NIH HHS; UM1 CA182934 United States CA NCI NIH HHS; UM1 CA182913 United States CA NCI NIH HHS; UM1 CA167462 United States CA NCI NIH HHS; P30 CA071789 United States CA NCI NIH HHS; U01 CA164973 United States CA NCI NIH HHS |
| فهرسة مساهمة: | Keywords: Alcohol; breast cancer; cohort study; epidemiology; estrogen receptor; folate; pooled analyses; progesterone receptor |
| المشرفين على المادة: | 0 (Receptors, Estrogen) 3K9958V90M (Ethanol) 935E97BOY8 (Folic Acid) |
| تواريخ الأحداث: | Date Created: 20150831 Date Completed: 20180104 Latest Revision: 20181113 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC5005939 |
| DOI: | 10.1093/ije/dyv156 |
| PMID: | 26320033 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1464-3685 |
|---|---|
| DOI: | 10.1093/ije/dyv156 |